Inventor
LIM YANGMI
KR2 patents
Patents
2 patentsUS11198733B2Dec 14, 2021
Pharmaceutical composition for inhibiting metastasis of cancer, comprising, as active ingredient, antibody that specifically binds to epidermal growth factor receptor
GREEN CROSS CORP0 citations42
US12534518B2Jan 27, 2026
Fusion protein comprising anti-mesothelin antibody, anti-CD3 antibody or anti-EGFR antibody, bispecific or trispecific antibody comprising same, and uses thereof
GREEN CROSS CORP0 citations37